Capital Flow Monitor · Sponsors · CIK 2122391
Vivo Opportunity Co-Invest (Cycle 3), L.P.
192 LYTTON AVENUE, PALO ALTO, CA, 94301 · (650) 688-0818
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
—
Sold
$0
% sold
—
Investors
0
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-25 | D ·current | 506(b) | — | $0 | — | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Vivo Opportunity, LLC — Promoter, Palo Alto, CA
-
Gaurav Aggarwal — Executive Officer, Palo Alto, CA
5 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Drakkar Co-Invest Fund, L.P. $0 of —
- Bonum Therapeutics, Inc. $26.9M of $32.3M · 83.3%
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
-
Kevin Dai — Executive Officer, Palo Alto, CA
2 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
-
Frank Kung — Executive Officer, Palo Alto, CA
4 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Drakkar Co-Invest Fund, L.P. $0 of —
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
-
Shan Fu — Executive Officer, Palo Alto, CA
4 other raises
- Vivo Opportunity Fund, L.P. $816.9M of —
- Vivo Drakkar Co-Invest Fund, L.P. $0 of —
- Vivo Capital Fund X, L.P. $717.0M of —
- Vivo Opportunity Cayman Fund, L.P. $148.5M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.